ASND icon

Ascendis Pharma
ASND

Overview Fund Activity

102 hedge funds and large institutions have $2.63B invested in Ascendis Pharma in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+10
Holders Change %
+10.87%
% of All Funds
2.34%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.28%
New
19
Increased
38
Reduced
30
Closed
8
Calls
$32.5M
Puts
$5.92M
Net Calls
+$26.6M
Net Calls Change
+$26.6M

Top Buyers

1
O
OrbiMed
New York
+$69.6M
2
LCM
Lakewood Capital Management
New York
+$30M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$28.2M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.7M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$14.5M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$25.6M
2
EC
EcoR1 Capital
California
-$23.8M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$23.3M
4
ACP
Acuta Capital Partners
California
-$15.5M
5
FCMI
Foresite Capital Management IV
California
-$13.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
DZ Bank
101
DZ Bank
Germany
– -$1.24M -19,000 Closed
Neuberger Berman Group
102
Neuberger Berman Group
New York
– -$916K -14,000 Closed
Tudor Investment Corp
103
Tudor Investment Corp
Connecticut
– -$766K -11,705 Closed
JPMorgan Chase & Co
104
JPMorgan Chase & Co
New York
– -$255K -3,899 Closed
Jane Street
105
Jane Street
New York
– -$250K -3,817 Closed
VF
106
Virtu Financial
New York
– -$227K -3,478 Closed
APP
107
Avantax Planning Partners
Iowa
– -$13K -200 Closed
Citigroup
108
Citigroup
New York
– -$9K -142 Closed
1 2 3 4
5